01029nam a2200277 i 450099100215545970753620020508191418.0010704s1978 it ||| | ita b10967412-39ule_instPARLA156333ExLDip.to Filosofiaita155Reynolds, Vernon161008La biologia dell'azione umana :per una biosociologia della conoscenza /di Vernon ReynoldsMilano :Edizioni scientifiche e tecniche Mondadori,[1978]309 p. :ill. ;22 cm.Biblioteca della ESTTit. orig.: The biology of human actionBiopsicologiaComportamento.b1096741223-02-1728-06-02991002155459707536LE005IF XXXIII D 191LE005IFA-14090le005-E0.00-l- 00000.i1107771228-06-02Biologia dell'azione umana863439UNISALENTOle00501-01-01ma -itait 3102595nam 2200541 a 450 991069959630332120230902162034.0(CKB)5470000002402959(OCoLC)681537092(EXLCZ)99547000000240295920101116d2008 ua 0engurbn|||||||||txtrdacontentcrdamediacrrdacarrierEducation and employment outcomes of the Ronald E. McNair Postbaccalaureate Achievement Program alumni[electronic resource] /by Ann McCoy, Anna Wilkinson, Russell Jackson ; prepared for U.S. Dept. of Education, Office of Planning, Evaluation and Policy Development, Policy and Program Studies ServiceWashington, D.C. :U.S. Dept. of Education, Office of Planning, Evaluation and Policy Development, Policy and Program Studies Service,2008.1 online resource (xiv, 76 pages) illustrationsTitle from title screen (viewed on Oct. 25, 2010)."March 2008"--T.p. verso."No Child Left Behind"--Cover."Prepared for the U.S. Department of Education under contract number ED-01-CO-0027 with Decision Information Resources, Inc."--T.p. verso.Includes bibliographical references (pages 37-38).Federal aid to higher educationUnited StatesPeople with social disabilitiesEducation (Higher)United StatesStatisticsMinoritiesEducation (Higher)United StatesStatisticsPoorEducation (Higher)United StatesStatisticsPeople with social disabilitiesEmploymentUnited StatesDegrees, AcademicUnited StatesStatisticsStatistics.lcgftFederal aid to higher educationPeople with social disabilitiesEducation (Higher)MinoritiesEducation (Higher)PoorEducation (Higher)People with social disabilitiesEmploymentDegrees, AcademicMcCoy Ann1405096Wilkinson Anna1405097Jackson Russell165665United States.Department of Education.Policy and Program Studies Service.Decision Information Resources, Inc.GPOGPOBOOK9910699596303321Education and employment outcomes of the Ronald E. McNair Postbaccalaureate Achievement Program alumni3481011UNINA03906nam 2200625 a 450 991083062120332120230421044510.01-282-34805-197866123480510-470-51539-20-470-51540-6(CKB)1000000000376023(EBL)470448(OCoLC)609849347(SSID)ssj0000305014(PQKBManifestationID)11259778(PQKBTitleCode)TC0000305014(PQKBWorkID)10285230(PQKB)11605647(MiAaPQ)EBC470448(EXLCZ)99100000000037602319970602d1997 uy 0engur|n|---|||||txtccrOligonucleotides as therapeutic agents[electronic resource] /[editors, Derek J. Chadwick (Organizer) and Gail Cardew]Chichester ;New York Wiley19971 online resource (262 p.)Ciba Foundation symposium ;209Proceedings of the Symposium on Oligonucleotides as Therapeutic Agents, held at Ciba Foundation on 7-9 January 1997.0-471-97279-7 Includes bibliographical references and indexes.OLIGONUCLEOTIDES AS THERAPEUTIC AGENTS; Contents; Participants; Introduction; Oligoncleotide analogues: an overview; Phosphorothioate oligodeox ynucleotides: large-scale synthesis and analysis, impurity characterization, and the effects of phosphorus stereochemistry; Discovering antisense reagents by hybridization of RNA to oligonucleotide arrays; Pharrnacokinetics of oligonucleotides in cell culture; Pharrnacokinetics of oligonucleotides; Controversies in the cellular pharmacology of oligodeox ynucleotides; Sequence-specific control of gene expression by antigene and clamp oligonucleotidesFirst- and second-generation antisense oligonucleotide inhibitors targeted against human c-raf kinaseDifferential oligonucleotide activity in cell culture versus mouse models; Structure-activity relationships in cell culture; Progress in antisense therapeutics discovery and development; Oligonucleotide therapeutics for human leukemia; Therapeutic applications of catalytic antisense RNAs (ribozymes); Exogenous application of riboaymes for inhibiting gene expression; Efficient process technologies for the preparation of oligonucleotidesIn vivo production of oligodeoxyribonucleotides of specific sequences: application to antisense DNASummary; Index of contributors; Subject indexThe use of oligonucleotides as therapeutic agents rests upon their ability to interfere, in a sequence-specific manner, with the fundamental machinery of protein synthesis either by binding to the mRNAs transcribed from a gene or by binding directly to a target gene. This approach can be used not only for inhibition of the synthesis of host proteins but also of those required by invading pathogens. Potential therapeutic applications are enormous, ranging over hypertension, cardiovascular disease, autoimmune disease, vital and other parasitic infections (especially HIV), and cancer. This book dCiba Foundation symposium ;209.OligonucleotidesTherapeutic useCongressesAntisense nucleic acidsTherapeutic useCongressesOligonucleotidesTherapeutic useAntisense nucleic acidsTherapeutic use615615.31Chadwick Derek91632Cardew Gail857118Symposium on Oligonucleotides as Therapeutic Agents(1997 :Ciba Foundation)MiAaPQMiAaPQMiAaPQBOOK9910830621203321Oligonucleotides as therapeutic agents2013976UNINA